Alphamab Oncology (HKG:9966)

Alphamab Oncology Statistics

Total Valuation

HKG:9966 has a market cap or net worth of HKD 9.13 billion. The enterprise value is 7.63 billion.

Market Cap	9.13B
Enterprise Value	7.63B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:9966 has 968.57 million shares outstanding. The number of shares has increased by 3.37% in one year.

Current Share Class	968.57M
Shares Outstanding	968.57M
Shares Change (YoY)	+3.37%
Shares Change (QoQ)	-2.06%
Owned by Insiders (%)	50.12%
Owned by Institutions (%)	2.69%
Float	483.14M

Valuation Ratios

The trailing PE ratio is 36.42.

PE Ratio	36.42
Forward PE	n/a
PS Ratio	10.61
PB Ratio	4.49
P/TBV Ratio	4.49
P/FCF Ratio	38.30
P/OCF Ratio	32.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.84, with an EV/FCF ratio of 32.00.

EV / Earnings	29.91
EV / Sales	8.86
EV / EBITDA	26.84
EV / EBIT	37.03
EV / FCF	32.00

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.15.

Current Ratio	4.98
Quick Ratio	4.75
Debt / Equity	0.15
Debt / EBITDA	1.05
Debt / FCF	1.26
Interest Coverage	22.64

Financial Efficiency

Return on equity (ROE) is 13.37% and return on invested capital (ROIC) is 5.76%.

Return on Equity (ROE)	13.37%
Return on Assets (ROA)	5.22%
Return on Invested Capital (ROIC)	5.76%
Return on Capital Employed (ROCE)	9.45%
Revenue Per Employee	1.78M
Profits Per Employee	527,091
Employee Count	420
Asset Turnover	0.35
Inventory Turnover	0.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +196.54% in the last 52 weeks. The beta is 0.49, so HKG:9966's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	+196.54%
50-Day Moving Average	10.26
200-Day Moving Average	9.51
Relative Strength Index (RSI)	37.87
Average Volume (20 Days)	1,770,221

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9966 had revenue of HKD 861.24 million and earned 255.11 million in profits. Earnings per share was 0.26.

Revenue	861.24M
Gross Profit	794.65M
Operating Income	206.08M
Pretax Income	255.11M
Net Income	255.11M
EBITDA	275.94M
EBIT	206.08M
Earnings Per Share (EPS)	0.26

Balance Sheet

The company has 1.80 billion in cash and 299.68 million in debt, with a net cash position of 1.50 billion or 1.55 per share.

Cash & Cash Equivalents	1.80B
Total Debt	299.68M
Net Cash	1.50B
Net Cash Per Share	1.55
Equity (Book Value)	2.03B
Book Value Per Share	2.11
Working Capital	1.61B

Cash Flow

In the last 12 months, operating cash flow was 281.05 million and capital expenditures -42.59 million, giving a free cash flow of 238.46 million.

Operating Cash Flow	281.05M
Capital Expenditures	-42.59M
Free Cash Flow	238.46M
FCF Per Share	0.25

Margins

Gross margin is 92.27%, with operating and profit margins of 23.93% and 29.62%.

Gross Margin	92.27%
Operating Margin	23.93%
Pretax Margin	29.62%
Profit Margin	29.62%
EBITDA Margin	32.04%
EBIT Margin	23.93%
FCF Margin	27.69%

Dividends & Yields

HKG:9966 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.37%
Shareholder Yield	-3.37%
Earnings Yield	2.79%
FCF Yield	2.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9966 has an Altman Z-Score of 4.94 and a Piotroski F-Score of 7.

Altman Z-Score	4.94
Piotroski F-Score	7